Name: Pharmaceuticals, Corporate Crime and Public Health (en Inglés)
Price: 89870.00 CLP
Availability: InStock
Author: Graham Dukes;John Braithwaite;J. P. Moloney
ISBN: 9781784713614

portada Pharmaceuticals, Corporate Crime and Public Health (en Inglés)

Pharmaceuticals, Corporate Crime and Public Health (en Inglés)

Formato

Libro Físico

Editorial

Edward Elgar Publishing

Autor

Graham Dukes;John Braithwaite;J. P. Moloney

Año

2015

Idioma

Inglés

N° páginas

424

Encuadernación

Tapa Blanda

Dimensiones

23.40 x 15.60 cm

ISBN13

9781784713614

Pharmaceuticals, Corporate Crime and Public Health (en Inglés)

Graham Dukes;John Braithwaite;J. P. Moloney (Autor) · Edward Elgar Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 19 a 24 días háb.

$ 149.790$ 89.870

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 51 unidades

$ 89.870

Llega entre el 11 Ago y el 18 Ago a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Pharmaceuticals, Corporate Crime and Public Health (en Inglés)"

The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behavior, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media.

Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities - research, manufacturing, information, distribution and pricing - as well as some questionable aspects of its relationship with society.

Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies.